Patent · US Active

Chemical compounds

US7816391B2 · kind B2 · utility

3Cited by
1References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 28, 2008
Grant dateOct 19, 2010
Priority date
Expiry dateOct 28, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound of formula (I):and pharmaceutically-acceptable salts thereof wherein the variable groups are defined within; their use in the inhibition of 11βHSD1, processes for making them and pharmaceutical compositions comprising them are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.